The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior

Journal of Neuroscience

Volumn 28, Issue 1, 2008, Pages 68-79

  Du, Jing ^a   Creson, Thomas K ^a   Wu, Long Jun ^b   Ren, Ming ^b   Gray, Neil A ^a   Falke, Cynthia ^a   Wei, Yanling ^a   Wang, Yun ^a   Blumenthal, Rayah ^a   Machado Vieira, Rodrigo ^a   Yuan, Peixiong ^a   Chen, Guang ^a   Zhuo, Min ^b   Manji, Husseini K ^a,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

AMPA; Lithium; Manic like behavior; Phosphorylation; PKA; Valproate

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; AMPA RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 2; LITHIUM; SYNTHETIC PEPTIDE; TAT S845; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; MALE; MANIA; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; ANTIMANIC AGENTS; BEHAVIOR, ANIMAL; BENZODIAZEPINES; BIPOLAR DISORDER; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EMBRYO, MAMMALIAN; EXCITATORY AMINO ACID ANTAGONISTS; EXPLORATORY BEHAVIOR; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; NEURONS; PATCH-CLAMP TECHNIQUES; RATS; RATS, INBRED WKY; RECEPTORS, AMPA; SYNAPTOSOMES; VALPROIC ACID;

EID: 38149100380     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3080-07.2008     Document Type: Article

References (63)

1. Atmaca M, Yildirim H, Ozdemir H, Ogur E, Tezcan E (2007) Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine. Psychol Med 37:121-129.
2. Banke TG, Bowie D, Lee H, Huganir RL, Schousboe A, Traynelis SF (2000) Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase. J Neurosci 20:89-102.
3. Barria A, Derkach V, Soderling T (1997) Identification of the Ca2+/calmodulin-dependent protein kinase II regulatory phosphorylation site in the alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate-type glutamate receptor. J Biol Chem 272:32727-32730.
4. Beaulieu JM, Sotnikova TD, Yao WD, Kockeritz L, Woodgett JR, Gainetdinov RR, Caron MG (2004) Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci USA 101:5099-5104.
5. Brambilla P, Barale F, Caverzasi E, Soares JC (2002) Anatomical MRI findings in mood and anxiety disorders. Epidemiol Psichiatr Soc 11:88-99.
6. Brebner K, Wong TP, Liu L, Liu Y, Campsall P, Gray S, Phelps L, Phillips AG, Wang YT (2005) Nucleus accumbens long-term depression and the expression of behavioral sensitization. Science 310:1340-1343.
7. Cao G, Pei W, Ge H, Liang Q, Luo Y, Sharp FR, Lu A, Ran R, Graham SH, Chen J (2002) In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis. J Neurosci 22:5423-5431.
8. Carlezon Jr WA, Nestler EJ (2002) Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse? Trends Neurosci 25:610-615.
9. Carlson PJ, Singh JB, Zarate Jr CA, Drevets WC, Manji HK (2006) Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets. NeuroRx 3:22-41.
10. Chao SZ, Ariano MA, Peterson DA, Wolf ME (2002) D1 dopamine receptor stimulation increases GluR1 surface expression in nucleus accumbens neurons. J Neurochem 83:704-712.
11. Coyle JT, Duman RS (2003) Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 38:157-160.
12. Derkach V, Barria A, Soderling TR (1999) Ca2+/calmodulin-kinase II enhances channel conductance of alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionate type glutamate receptors. Proc Natl Acad Sci USA 96:3269-3274.
13. Drevets WC (2001) Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol 11:240-249.
14. Du J, Feng L, Yang F, Lu B (2000) Activity- and Ca(2+)-dependent modulation of surface expression of brain-derived neurotrophic factor receptors in hippocampal neurons. J Cell Biol 150:1423-1434.
15. Du J, Gould DT, Manji HK (2003a) Neurotrophic signaling in mood disorders. New York: Wiley.
16. Du J, Gray NA, Falke C, Yuan P, Szabo S, Manji HK (2003b) Structurally dissimilar antimanic agents modulate synaptic plasticity by regulating AMPA glutamate receptor subunit GluR1 synaptic expression. Ann NY Acad Sci 1003:378-380.
17. Du J, Gray NA, Falke CA, Chen W, Yuan P, Szabo ST, Einat H, Manji HK (2004) Modulation of synaptic plasticity by antimanic agents: the role of AMPA glutamate receptor subunit 1 synaptic expression. J Neurosci 24:6578-6589.
18. Du J, Suzuki K, Wei Y, Wang Y, Blumenthal R, Chen Z, Falke C, Zarate Jr CA, Manji HK (2006) The anticonvulsants lamotrigine, riluzole, and valproate differentially regulate AMPA receptor membrane localization: relationship to clinical effects in mood disorders. Neuropsychopharmacology 32:793-802.
19. Edwards S, Graham DL, Bachtell RK, Self DW (2007) Region-specific tolerance to cocaine-regulated cAMP-dependent protein phosphorylation following chronic self-administration. Eur J Neurosci 25:2201-2213.
20. Einat H, Manji HK (2006) Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder. Biol Psychiatry 59:1160-1171.
21. Esteban JA, Shi SH, Wilson C, Nuriya M, Huganir RL, Malinow R (2003) PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity. Nat Neurosci 6:136-143.
22. Frey BN, Andreazza AC, Rosa AR, Martins MR, Valvassori SS, Reus GZ, Hatch JP, Quevedo J, Kapczinski F (2006a) Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania. Behav Pharmacol 17:311-318.
23. Frey BN, Valvassori SS, Reus GZ, Martins MR, Petronilho FC, Bardini K, Dal-Pizzol F, Kapczinski F, Quevedo J (2006b) Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychiatry Neurosci 31:326-332.
24. Fu XZ, Zhang QG, Meng FJ, Zhang GY (2004) NMDA receptor-mediated immediate Ser831 phosphorylation of GluR1 through CaMKIIalpha in rat hippocampus during early global ischemia. Neurosci Res 48:85-91.
25. Gabriel SM, Roncancio JR, Ruiz NS (1992) Growth hormone pulsatility and the endocrine milieu during sexual maturation in male and female rats. Neuroendocrinology 56:619-625.
26. Goodwin FK, Jamison KR (2007) Manic-depressive illness: bipolar and recurrent unipolar disorders, Ed 2. New York: Oxford UP.
27. Hayashi Y, Shi SH, Esteban JA, Piccini A, Poncer JC, Malinow R (2000) Driving AMPA receptors into synapses by LTP and CaMKII: requirement for GluR1 and PDZ domain interaction. Science 287:2262-2267.
28. Hyman SE, Malenka RC, Nestler EJ (2006) Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29:565-598.
29. Judd LL, Akiskal HS (2003) The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord 73:123-131.
30. Lee HK, Barbarosie M, Kameyama K, Bear MF, Huganir RL (2000) Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity. Nature 405:955-959.
31. Liu L, Schulz SC, Lee S, Reutiman TJ, Fatemi SH (2007) Hippocampal CA1 pyramidal cell size is reduced in bipolar disorder. Cell Mol Neurobiol 27:351-358.
32. Loza B, Krolicki L, Papierski K, Mazurek I, Mosiolek A, Kokoszka A, Andrysiak R (2005) Psychophysiological analysis of bipolar disorder treatment with functional magnetic resonance imaging (fMRI), spectroscopic (1HMRS) and volumetric MRI assessment of CNS: report of three cases. Psychiatr Pol 39:1231-1236.
33. Malinow R (2003) AMPA receptor trafficking and long-term potentiation. Philos Trans R Soc Lond B Biol Sci 358:707-714.
34. Mammen AL, Kameyama K, Roche KW, Huganir RL (1997) Phosphorylation of the alpha-amino-3-hydroxy-5-methylisoxazole4-propionic acid receptor GluR1 subunit by calcium/calmodulin-dependent kinase II. J Biol Chem 272:32528-32533.
35. Manji HK, Lenox RH (1999) Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biol Psychiatry 46:1328-1351.
36. Manji HK, Lenox RH (2000) The nature of bipolar disorder. J Clin Psychiatry 61 [Supp 13]:42-57.
37. Manji HK, Drevets WC, Charney DS (2001) The cellular neurobiology of depression. Nat Med 7:541-547.
38. Meyers RA, Zavala AR, Neisewander JL (2003) Dorsal, but not ventral, hippocampal lesions disrupt cocaine place conditioning. NeuroReport 14:2127-2131.
39. Nestler EJ, Carlezon Jr WA (2006) The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59:1151-1159.
40. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM (2002) Neurobiology of depression. Neuron 34:13-25.
41. Passafaro M, Nakagawa T, Sala C, Sheng M (2003) Induction of dendritic spines by an extracellular domain of AMPA receptor subunit GluR2. Nature 424:677-681.
42. Peineau S, Taghibiglou C, Bradley C, Wong TP, Liu L, Lu J, Lo E, Wu D, Saule E, Bouschet T, Matthews P, Isaac JT, Bortolotto ZA, Y.T. W, Collingridge GL (2007) LTP inhibits LTD in the hippocampus via regulation of GSK3beta. Neuron 53:703-717.
43. Poncelet M, Dangoumau L, Soubrie P, Simon P (1987) Effects of neuroleptic drugs, clonidine and lithium on the expression of conditioned behavioral excitation in rats. Psychopharmacology (Berl) 92:393-397.
44. Pozzo-Miller LD, Gottschalk W, Zhang L, McDermott K, Du J, Gopalakrishnan R, Oho C, Sheng ZH, Lu B (1999) Impairments in high-frequency transmission, synaptic vesicle docking, and synaptic protein distribution in the hippocampus of BDNF knockout mice. J Neurosci 19:4972-4983.
45. Prien RF, Klett CJ, Caffey Jr EM (1973) Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. Arch Gen Psychiatry 29:420-425.
46. Prien RF, Kupfer DJ, Mansky PA, Small JG, Tuason VB, Voss CB, Johnson WE (1984) Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. Arch Gen Psychiatry 41:1096-1104.
47. Quinn R (2005) Comparing rat's to human's age: how old is my rat in people years? Nutrition 21:775-777.
48. Roche KW, O'Brien RJ, Mammen AL, Bernhardt J, Huganir RL (1996) Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit. Neuron 16:1179-1188.
49. Self DW (2002) Where's the excitement in psychostimulant sensitization? Neuropsychopharmacology 26:14-17.
50. Shaldubina A, Buccafusca R, Johanson RA, Agam G, Belmaker RH, Berry GT, Bersudsky Y (2007) Behavioural phenotyping of sodium-myo-inositol cotransporter heterozygous knockout mice with reduced brain inositol. Genes Brain Behav 6:253-259.
51. Sheng M, Lee SH (2001) AMPA receptor trafficking and the control of synaptic transmission. Cell 105:825-828.
52. Shi S, Hayashi Y, Esteban JA, Malinow R (2001) Subunit-specific rules governing AMPA receptor trafficking to synapses in hippocampal pyramidal neurons. Cell 105:331-343.
53. Snyder GL, Allen PB, Fienberg AA, Valle CG, Huganir RL, Nairn AC, Greengard P (2000) Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo. J Neurosci 20:4480-4488.
54. Takigawa M, Fukuzako H, Ueyama K, Tominaga H (1994) Intracranial selfstimulation and locomotor traces as indicators for evaluating and developing antipsychotic drugs. Jpn J Psychiatry Neurol 48:127-132.
55. Vandenberghe W, Nicoll RA, Bredt DS (2005) Interaction with the unfolded protein response reveals a role for stargazin in biosynthetic AMPA receptor transport. J Neurosci 25:1095-1102.
56. Velakoulis D, Wood SJ, Wong MT, McGorry PD, Yung A, Phillips L, Smith D, Brewer W, Proffitt T, Desmond P, Pantelis C (2006) Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch Gen Psychiatry 63:139-149.
57. Wenthold RJ, Petralia RS, Blahos II J, Niedzielski AS (1996) Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons. J Neurosci 16:1982-1989.
58. Wolf ME, Mangiavacchi S, Sun X (2003) Mechanisims by which dopmine receptors may influence synaptic plasticity. Ann NY Acad Sci 1003:241-249.
59. Wu LJ, Xu H, Ren M, Cao X, Zhuo M (2007) Pharmacological isolation of postsynaptic currents mediated by NR2A- and NR2B-containing NMDA receptors in the anterior cingulate cortex. Mol Pain 3:11.
60. Young LT (2007) Is bipolar disorder a mitochondrial disease? J Psychiatry Neurosci 32:160-161.
61. Yuan P, Chen G, Manji HK (1999) Lithium activates the c-Jun NH2-terminal kinases in vitro and in the CNS in vivo. J Neurochem 73:2299-2309.
62. Zemunik T, Peruzovic M, Capkun V, Milkovic K (2003) Behavioral characteristics of the offspring of adolescent rats. Braz J Med Biol Res 36:465-475.
63. Zhu JJ, Esteban JA, Hayashi Y, Malinow R (2000) Postnatal synaptic potentiation: delivery of GluR4-containing AMPA receptors by spontaneous activity. Nat Neurosci 3:1098-1106.